Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Axsome Therapeutics, Inc. | Director | Common Stock | 14.6K | $1.1M | $75.14 | May 29, 2024 | Direct |
Axsome Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 5.8K | Jun 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AXSM | Axsome Therapeutics, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
AXSM | Axsome Therapeutics, Inc. | May 28, 2024 | 2 | -$789K | 4 | May 29, 2024 | Director |
AXSM | Axsome Therapeutics, Inc. | Sep 15, 2023 | 4 | -$2.18M | 4 | Sep 15, 2023 | Director |
AXSM | Axsome Therapeutics, Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 6, 2023 | Director |
AXSM | Axsome Therapeutics, Inc. | Mar 2, 2023 | 1 | $0 | 4 | Mar 6, 2023 | Director |
AXSM | Axsome Therapeutics, Inc. | Jan 3, 2023 | 2 | $22.8K | 4 | Jan 4, 2023 | Director |
AXSM | Axsome Therapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 7, 2022 | Director |
AXSM | Axsome Therapeutics, Inc. | Mar 15, 2022 | 2 | $4.54K | 4 | Mar 17, 2022 | Director |
AXSM | Axsome Therapeutics, Inc. | Mar 4, 2022 | 1 | $0 | 4 | Mar 8, 2022 | Director |
AXSM | Axsome Therapeutics, Inc. | Nov 18, 2021 | 2 | $50.2K | 4 | Nov 22, 2021 | Director |
AXSM | Axsome Therapeutics, Inc. | Jun 4, 2021 | 1 | $0 | 4 | Jun 8, 2021 | Director |
AXSM | Axsome Therapeutics, Inc. | May 12, 2021 | 1 | $29.1K | 4 | May 13, 2021 | Director |